Patent details

EP3461821 Title: INDOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS

Basic Information

Publication number:
EP3461821
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP182054114
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INDOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS
French Title of Invention:
DÉRIVÉS D'INDOLE CARBOXAMIDE EN TANT QU'INHIBITEURS DE KINASE
German Title of Invention:
INDOLECARBOXAMIDEN-DERIVATE ALS KINASEINHIBITOREN
SPC Number:

Dates

Filing date:
23/10/2015
Grant date:
13/05/2020
EP Publication Date:
03/04/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/05/2020
EP B1 Publication Date:
13/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/05/2020
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
08/06/2020
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
WATTERSON, Scott Hunter
Address:
United States (US)

2

Name:
NGU, Khehyong
Address:
United States (US)

3

Name:
AHMAD, Saleem
Address:
United States (US)

4

Name:
LIU, Qingjie
Address:
United States (US)

5

Name:
GONG, Hua
Address:
United States (US)

6

Name:
TEBBEN, Andrew J
Address:
United States (US)

Priority

Priority Number:
201462068225 P
Priority Date:
24/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4045; A61P 29/00; A61P 37/00; C07D 209/18; C07D 401/04; C07D 401/06; C07D 401/12; C07D 403/04; C07D 403/10; C07D 403/12; C07D 413/04; C07D 417/04; C07D 471/04; C07D 487/04; C07D 487/10;

Publication

European Patent Bulletin

Issue number:
202020
Publication date:
13/05/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/10/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
10/06/2020 Outgoing Correspondence 1
08/06/2020 Power Of Attorney 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56